Table 1.

Baseline characteristics of the study population according to the presence of COVID-19 disease after kidney transplantation

Demographic CharacteristicsAll Patients, n=1216COVID-19–Positive Patients, n=66COVID-19–Negative Patients, n=1150P Valuea
Age, yr54.1±13.456.4±12.554.0±13.40.14
Men, no. (%)777 (64)37 (56)740 (64)0.17
Non-White, no. (%)222 (24)24 (36)198 (17)<0.001
Blood group, no. (%)0.90
 A463 (38)23 (35)440 (38)
 B194 (16)12 (18)182 (16)
 O489 (40)28 (42)461 (40)
 AB70 (6)3 (5)67 (6)
Cause of ESKD, no. (%)0.13
 Glomerulopathies254/1206 (21)7/66 (11)247/1140 (22)
 Diabetes195/1206 (16)12/66 (18)183/1140 (16)
 Vascular209/1206 (17)16/66 (24)196/1140 (17)
 Other548/1206 (46)31/66 (47)514/1140 (45)
Deceased donor, no. (%)1053 (87)64 (97)989 (86)<0.001
Prior kidney transplant, no. (%)132 (11)8 (12)124 (11)0.69
Time on dialysis prior to transplantation, mob49.4±4257.8±46.248.8±41.80.09
Multiorgan recipients, no. (%)96 (8)4 (6)92 (8)0.57
  • Plus-minus values are means ± SD.

  • a P values are for the comparisons between COVID-19–positive and COVID-19–negative patients.

  • b Time on dialysis prior to transplantation was available in 1078 patients.